Composition
- Active ingredients
- NELARABINE 375MG/75ML (5MG/ML)
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- NELARABINE 250MG/50ML (5MG/ML) · InjectableANDA216510-001 · Prescription
- NELARABINE 250MG/50ML (5MG/ML) · InjectableANDA216948-001 · Prescription
- NELARABINE 250MG/50ML (5MG/ML) · InjectableANDA218554-001 · Prescription
- NELARABINE 250MG/50ML (5MG/ML) · InjectableANDA216346-001 · Prescription
- NELARABINE 250MG/50ML (5MG/ML) · InjectableANDA212605-001 · Prescription
- NELARABINE 375MG/75ML (5MG/ML) · InjectableThis page
- NELARABINE 250MG/50ML (5MG/ML) · InjectableANDA214809-001 · Prescription
- NELARABINE 250MG/50ML (5MG/ML) · InjectableANDA215057-001 · Prescription
- NELARABINE 250MG/50ML (5MG/ML) · InjectableANDA216038-001 · Prescription
- NELARABINE 250MG/50ML (5MG/ML) · InjectableANDA215037-001 · Prescription
- NELARABINE 250MG/50ML (5MG/ML) · InjectableANDA216934-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA214809.
At a glance
- Brand name
- Nelarabine
- Route
- Intravenous
- Dosage form
- Injectable
- Applicant
- Shorla
- Status
- Prescription
- FDA approval
- 3 Mar 2023
- Application
- ANDA214809-002